Did you hear the joke about the centipede that was dying of old age?
The doctor told him he was on his last legs…
Yes, I know that joke is terrible, and I am sorry, but it’s on topic – I promise.
That’s because, unlike the centipede which can have anywhere from 20 to 300 legs, most people are limited to only two – and while this may seem a little limiting, it does have at least one benefit.
Can you imagine trying to treat osteoarthritis in 300 legs at once?
Osteoarthritis is also sometimes called “wear and tear” arthritis, and it affects over 8.5 million people in the UK alone, most commonly in the knees. (See, I told you it was on topic!)
An innovative treatment option available from the London Cartilage Clinic utilizes a unique hydrogel compound to cushion and lubricate your knee joint, with several important benefits over traditional injections or regenerative treatments.
Visit https://londoncartilage.com/arthrosamid to learn more about the London Cartilage Clinic and osteoarthritis treatments.
Though osteoarthritis has no cure, the treatment from the London Cartilage Clinic has been shown to provide longer-lasting relief than other options, given Arthrosamid’s potential to integrate into the soft synovial tissue in the joint capsule. With the treatment, research has shown that pain relief can last for up to one year, and other beneficial effects can last for several years, from a single injection.
Prior to Arthrosamid injections, treatment options that could reduce your pain and improve your mobility were available, but they were often short-term solutions with the potential to cause damage to any remaining cartilage. In contrast, side effects of Arthrosamid are both minimal and short-term, with the most common being temporary pain or swelling at the injection site.
The hydrogel works by forming a cushion-like membrane inside of the joint, that provides protection for your knee, as well as lubrication. Since the hydrogel is non-biodegradable, long-lasting, and cannot be absorbed by your body, some experts believe this could lead to an effective cure for osteoarthritis.
What does the evidence say though? There have been too many studies done on this technique to look at them all individually, but we can use a shortcut and examine a recent analysis that looked at them all together, comparing outcomes for up to two years after treatment.
In this comprehensive review of studies done on Arthrosamid (1), researchers concluded that “this [Arthrosamid] hydrogel seems to be an efficacious and safe treatment option for knee OA and provides positive results for at least 2 years.” The researchers assessed outcomes from hundreds of patients and found that while the treatment provides pain relief and improved mobility for at least one to two years, there were no lasting adverse side effects reported.
The London Cartilage Clinic is staffed by some of the UK’s top medical specialists and offers a full range of treatments ranging from Arthrosamid injections and cartilage supplements to cell therapy and biological scaffolding.
One satisfied patient said, “The whole care pathway from admission to discharge was streamlined and characterised by caring staff. Prof Lee is competent, multi-talented, and approachable. He was reassuring before, during and after the procedure; and above all else, was kind to me.”
Whether you have one, two, or two hundred legs, it’s important to take care of them, and Arthrosamid can help.
If you’re suffering from knee pain or a lack of mobility caused by osteoarthritis, contact the London Cartilage Clinic to see if they can help. Even if Arthrosamid is not right for you, their expert staff can help you find a treatment that is.
Visit https://londoncartilage.com/arthrosamid to learn more about osteoarthritis treatments, Arthrosamid injections, and the London Cartilage Clinic.
A Cole, R Maulana, et al., 2022. A Systematic Review of the Novel Compound Arthrosamid Polyacrylamide (PAAG) Hydrogel for Treatment of Knee Osteoarthritis, Medical Research Archives, [online] 10(8). https://doi.org/10.18103/mra.v10i8.2950
Comments are closed.